Vitamin D supplementation and smoking cessation may protect cognitive function over time in patients with clinically isolated syndrome (CIS), a condition that is thought to indicate a first course in multiple sclerosis (MS), according to new research.
An October 18, 2018 article in Multiple Sclerosis News Today explored research on CIS led by Marianna Cortese, a fellow in the Neuroepidemiology Research Group at Harvard T.H. Chan School of Public Health. The research, presented at the 34th congress of the European Committee for Treatment and Research in Multiple Sclerosis, indicated that high vitamin D levels predicted better cognitive function over an 11-year period in patients with CIS while smoking was associated with worsening cognitive ability.
Read the Multiple Sclerosis News Today article: High Vitamin D Levels, Smoking Predict Opposite Effects on Cognition in CIS Patients, Study Suggests